Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 373-376

  Pathak, Sen ^a,b   Multani, Asha S ^a   Ozen, Mustafa ^a   Richardson, Mary A ^a   Newman, Robert A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Dolastatin 10; Polyploidy; Telomeric association

Indexed keywords

ANTINEOPLASTIC AGENT; DOLASTATIN 10;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FLUORESCENCE IN SITU HYBRIDIZATION; MELANOMA CELL; METAPHASE; METASTASIS; MICROTUBULE; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; TELOMERE;

EID: 0031912028     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.2.373     Document Type: Article

References (17)

1. Pettit GR, Kamano Y, Herald CL, Tuinman AA, Boettner FE, Kizu H, Schmidt JM, Bacqynskyj L, Tomer KB and Bontems RJ: The isolation and structure of a remarkable marine animal antineoplastic constituent: Dolastatin 10. J Am Chem Soc 109: 6883-6885, 1987.
2. Pettit GR, Kamano Y, Herald CL, Fujii Y, Kizu H, Boyd MR, Boettner FE, Doubek, DL, Schmidt JM, Chapuis J-C and Michel C: Isolation of Dolastatins 10-15 from the marine mollusk Dolabella auricularia. Tetrahedron 49: 9151-9170, 1993.
3. Hu ZB, Gignac SM, Quentmeier H, Pettit GR and Drexler HG: Effects of dolastatins on human B-lymphocytic leukemia cell lines. Leukemia Res 17: 333-339, 1993.
4. Bai R, Pettit GR and Harnel E: Binding of Dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and Vinca alkaloid sites. J Biol Chem 265: 17141-17149, 1990.
5. Bai R, Roach MC, Jayaram SK, Barkoczy NJ, Pettit GR, Ludueña RF and Hamel E: Differential effects of active isomers, segments, and analogs of Dolastatin 10 on ligand interactions with tubulin. Biochem Pharmacol 45: 1503-1515, 1993.
6. Bai R, Taylor GF, Schmidt JM, Williams MD, Kepler JA, Pettit GR and Hamel E: Interaction of Dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions. Mol Pharmacol 47: 965-976, 1995.
7. Hamel E: Natural products which interact with tubulin in the Vinca domain: maytansive, rhizoxin, phomopsin A, Dolastatin 10 and 15 and halichondrin B. Pharmacol Ther 55: 31-51, 1992.
8. Fidler IJ and Talmadge JE: Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res 46: 5167-5171, 1986.
9. Pathak S, Staroselsky AH and Fidler IJ: Specific chromosomal defects associated with metastatic potential in K-1735 melanoma clones: involvement of chromosomes 4 and 14. Cancer Genet Cytogenet 56: 209-221, 1991.
10. Pathak S: Chromosome banding techniques. J Reprod Med 17: 25-28, 1976.
11. Multani AS, Hopwood VL an Pathak S: A modified fluorescence in situ hybridization (FISH) technique. Anticancer Res 16: 3435-3438, 1996.
12. Pathak S, Multani AS and Amoss MS Jr: Telomere, telomerase and malignant melanomas in human and domestic mammals. Arch Zootec 45: 141-149, 1996.
13. Multani AS, Li C, Ozen M, Yadav M, Yu D-F, Wallace D and Pathak S: Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line. Anticancer Res (in press).
14. De Arruda M, Cocchiaro CA, Nelson CM, Grinnell CM, Janssen B, Haupt A and Barlozzari T: LU 103793 (NSC D-66356): a synthetic peptide that interacts with microtubules and inhibits mitosis. Cancer Res 55: 3085-3092, 1995.
15. Pathak S, Risin S, Brown NM and Berry K: Telomeric association of chromosomes is an early manifestation of programmed cell death. Int J Oncol 4: 323-328, 1994.
16. Pathak S, Dave BJ and Gagos SH: Chromosome alterations in cancer development and apoptosis. In Vivo 8: 843-850, 1994.
17. Pathak S and Amoss MS Jr: Genetic predisposition and specific chromosomal defects associated with Sinclair swine malignant melanoma. Int J Oncol 11: 53-57, 1997.